SCHEMBL1800

SCHEMBL1800

CCOC(=O)C1(c2ccc(-c3ccc(-c4onc(C)c4N(C)CCCc4ccc(OC)cc4)cc3)cc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 2/20 0.41
CHRM2 P08172 1/20 0.41
CHRM5 P08912 1/20 0.39
CHRM3 P20309 1/20 0.39
KCNA3 P22001 1/20 0.38
BRD4 O60885 1/20 0.38
POLB P06746 4/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 1/20 0.38
LMNA P02545 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ALOX5 P09917 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SLC6A9 P48067 1/20 0.35
ALDH1A1 P00352 2/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7201 0.95 CHRM1 (0.42) CHRM1CHRM2CHRM5CHRM3KCNA3
SCHEMBL1127 0.91 LPAR1 (0.43) CHRM1CHRM2CHRM5CHRM3POLB
SCHEMBL1323 0.91 OPRM1 (0.44) CHRM1CHRM2KCNA3CYP2C9LMNA
SCHEMBL1934 0.91 KCNA3 (0.48) KCNA3CYP2C9MEN1KMT2AALDH1A1
SCHEMBL7532 0.88 ALOX5 (0.35) CHRM1CHRM2CHRM5CHRM3BRD4
SCHEMBL7666 0.86 ABCC3 (0.44) CHRM1CHRM2CHRM5CHRM3POLB
SCHEMBL6605 0.85 ABCC3 (0.38) CYP2C9ABCC3ABCC4ABCB11CYP2C8
SCHEMBL6613 0.85 FFAR4 (0.35) CHRM1CHRM5CHRM3POLBLMNA
SCHEMBL2284 0.84 NPSR1 (0.43) KCNA3POLBCYP2C9LMNANPSR1
SCHEMBL1568 0.84 KCNA3 (0.39) CHRM1CHRM2KCNA3POLBCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
EP-2483253-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed
WO-2011041729-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed